Zai Lab Limited (NASDAQ:ZLAB – Get Free Report) shares gapped down prior to trading on Wednesday . The stock had previously closed at $18.46, but opened at $17.73. Zai Lab shares last traded at $17.83, with a volume of 35,690 shares. Analyst Upgrades and Downgrades Separately, Citigroup reduced their target price on Zai Lab from […]
Baron Funds, an investment management company, released its “Baron Emerging Markets Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here.
Zai Lab begins topical IL-17 trial for mild to moderate psoriasis healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Innoviva : Zai Lab and Innoviva Specialty Therapeutics Announce NMPA Approval for XACDURO® (Sulbactam Durlobactam or SUL DUR) for Hospital Acquired and Ventilator Associated Pneumonia Caused by Acinetobacter Baumannii Calcoaceticus Complex in China marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.